(Q35058121)

6 August 2017

1 reference

title

Therapeutic angiogenesis: protein-based therapy for coronary artery disease (English)

1 reference

6 August 2017

main subject

coronary artery disease

1 reference

Tanveer A Khan

1

1 reference

6 August 2017

Frank W Sellke

series ordinal

2

1 reference

6 August 2017

Roger J Laham

series ordinal

3

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

Expert Opinion on Pharmacotherapy

6 August 2017

published in

1 reference

6 August 2017

volume

4

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

219-226

1 reference

Isolation of putative progenitor endothelial cells for angiogenesis

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.219

Mechanisms of angiogenesis and arteriogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.219

Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.219

Angiogenesis in cardiovascular disease: current status and therapeutic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.219

Therapeutic angiogenesis in cardiology using protein formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.219

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.219

Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.219

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.219

FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.219

Vascular endothelial growth factor enhances atherosclerotic plaque progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.219

Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat--angiogenesis and angioma formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.219

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.219

Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.219

Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.219

Gene transfer for angiogenesis in coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.219

Gene transfer to induce angiogenesis in myocardial and limb ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.219

Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.219

Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.219

Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.219

Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.219

Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.219

Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.219

Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.219

Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.2.219

21 January 2018

Identifiers

DOI

10.1517/14656566.4.2.219

1 reference

6 August 2017

1 reference